Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Korea United PharmXKRX:033270 -1.38%90 OCF Margin % is 17.74% as of Jun. 2026, which is 2% above its 10-year median of 17.32. GuruFocus rates XKRX:033270 with a GF Score™ of 90/100 and a GF Value™ of ₩20,354.74 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 960 Drug Manufacturers companies, Korea United Pharm ranks better than 91.25% on this metric.
The historical rank and industry rank for Korea United Pharm's OCF Margin % or its related term are showing as below:
XKRX:033270'
s OCF Margin % Range Over the Past 10 Years
Min: 9.28 Med: 17.32 Max: 24.3
Current: 28.06
During the past 13 years, the highest OCF Margin % of Korea United Pharm was 24.30%. The lowest was 9.28%. And the median was 17.32%.
XKRX:033270's OCF Margin % is ranked better than 91.25% of 960
companies
in the Drug Manufacturers industry
Industry Median: 9.75
vs XKRX:033270: 28.06
The historical data trend for Korea United Pharm's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Korea United Pharm's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Korea United Pharm OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Korea United Pharm's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Korea United Pharm's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Korea United Pharm (XKRX:033270) has a OCF Margin % of 17.74% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Korea United Pharm and its competitors. This is near median its historical median of 17.32. Over the past decade, Korea United Pharm's OCF Margin % has ranged from 9.28 to 24.30. According to the industry distribution chart, Korea United Pharm ranks #84 out of 960 companies in the Drug Manufacturers industry, placing it in the top 8.7%.
Is Korea United Pharm's OCF Margin % too high?
Korea United Pharm's current OCF Margin % of 17.74% is near median its 10-year median of 17.32. Over the past 10 years, this metric has ranged from a low of 9.28 to a high of 24.30. The Drug Manufacturers industry median OCF Margin % is 9.75. Korea United Pharm's value of 17.74% is 81.9% above this industry median. Based on the distribution chart, Korea United Pharm ranks #84 out of 960 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Korea United Pharm has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Korea United Pharm's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Korea United Pharm ranks #84 out of 960 companies for OCF Margin %. This places Korea United Pharm in the top 9% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.75. Korea United Pharm's value of 17.74% is 81.9% above this benchmark. Historically, Korea United Pharm's own OCF Margin % has ranged from 9.28 to 24.30 over the past decade. While the company's 10-year median is 17.32 vs. the industry median of 9.75, Korea United Pharm has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.75, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Korea United Pharm's current OCF Margin % of 17.74% is 81.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Korea United Pharm and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Korea United Pharm's current OCF Margin % is 17.74%, which is near median its own 10-year median of 17.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Korea United Pharm stock overvalued right now?
Based on GuruFocus' analysis, Korea United Pharm (XKRX:033270) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩20,354.74, compared to a current price of ₩17,910.00 — trading 12% below its estimated fair value. The current OCF Margin % is 17.74%, which is near median its 10-year median of 17.32 and 81.9% above the Drug Manufacturers industry median of 9.75. Korea United Pharm's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Korea United Pharm (XKRX:033270), the current OCF Margin % is 17.74% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Korea United Pharm (XKRX:033270) Overvalued in 2026?
Based on GuruFocus' analysis, Korea United Pharm stock appears to be undervalued.
The current stock price of ₩17,910.00 is trading 12% below its estimated GF Value™ of ₩20,354.74.
GuruFocus considers Korea United Pharm to be Modestly Undervalued.
Key valuation signals for XKRX:033270:
OCF Margin %: 17.74% (near median its 10-year median of 17.32)
GF Value™: ₩20,354.74 vs. price of ₩17,910.00 (12% below fair value)
Industry Position: 81.9% above the Drug Manufacturers median (#84 of 960)
No single metric tells the full story. See the XKRX:033270 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Korea United Pharm Inc is a South Korea based company engages in the manufacture and distribution of pharmaceuticals and healthcare products. It offers incrementally modified drug, anti-cancer, prescription, and OTC products.
90GF Score
Get the complete analysis for XKRX:033270
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:033270 has been successfully added to your 
